A selective, potent, and orally bioavailable CDK7 inhibitor demonstrates superior anti-cancer activity in colorectal cancer models

被引：0
|
作者：
Park, Heuijoon
Seo, Kyoungwan
Yu, Jihyun
Kim, Jieun
Joo, Min Sung
Kim, Sungeun
Lee, Joonhyung
Lee, Jeonghyeon
Kim, Eun-Jung
Nam, Joonwoo
Han, Wooseok
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-LB168
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB168
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity
    Leger, Paul R.
    Hu, Dennis X.
    Biannic, Berenger
    Bui, Minna
    Han, Xinping
    Karbarz, Emily
    Maung, Jack
    Okano, Akinori
    Osipov, Maksim
    Shibuya, Grant M.
    Young, Kyle
    Higgs, Christopher
    Abraham, Betty
    Bradford, Delia
    Cho, Cynthia
    Colas, Christophe
    Jacobson, Scott
    Ohol, Yamini M.
    Pookot, Deepa
    Rana, Payal
    Sanchez, Jerick
    Shah, Niket
    Sun, Michael
    Wong, Steve
    Brockstedt, Dirk G.
    Kassner, Paul D.
    Schwarz, Jacob B.
    Wustrow, David J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (10) : 5398 - 5420
  • [42] Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer models
    Pinto, Nicole
    Prokopec, Stephenie D.
    Ghasemi, Farhad
    Meens, Jalna
    Ruicci, Kara M.
    Khan, Imran M.
    Mundi, Neil
    Patel, Krupal
    Han, Myung W.
    Yoo, John
    Fung, Kevin
    MacNeil, Danielle
    Mymryk, Joe S.
    Datti, Alessandro
    Barrett, John W.
    Boutros, Paul C.
    Ailles, Laurie
    Nichols, Anthony C.
    PLOS ONE, 2020, 15 (09):
  • [43] CT7001: An orally bioavailable CDK7 inhibitor is a potential therapy for breast, small-cell lung and haematological cancers
    Ainscow, Edward K.
    Leishman, Andrew
    Sullivan, Elaine
    Li, Bo
    Gallagher, William
    Peall, Adam
    Clark, Kristopher
    Thomson, Stuart
    Ali, Simak
    Coombes, Raoul C.
    Bahl, Ash
    CANCER RESEARCH, 2018, 78 (13)
  • [44] Aminocarboxymethylthiophenes (ACT) as potent and selective anti-cancer agents
    Jejcic, Alenka
    Thomas, Joice
    Romagnoli, Romeo
    Dehaen, Wim
    Balzarini, Jan
    Liekens, Sandra
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S94 - S94
  • [45] A selective Cdk12/13 non-covalent inhibitor with potent anti-breast cancer activity
    Quereda, V.
    Bayle, S.
    Francesca, V.
    Andrii, M.
    William, R.
    Derek, D.
    CANCER RESEARCH, 2019, 79 (04)
  • [46] Trial in progress: Phase I study of SY-5609, a potent, selective CDK7 inhibitor, with initial expansion in adults with metastatic pancreatic cancer
    Sharma, Manish
    Bashir, Babar
    Juric, Dejan
    Hamilton, Erika P.
    Papadopoulos, Kyriakos P.
    Ulahannan, Susanna Varkey
    Shapiro, Geoffrey
    Sahai, Vaibhav
    Mettu, Niharika B.
    Mita, Monica M.
    Akce, Mehmet
    Tao, Jessica
    Hodgson, Graeme
    Ke, Nan
    Henry, Susan
    Paul, Sofia
    Lodaya, Neha
    Madigan, Catherine
    Roth, David A.
    Klimek, Virginia
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] Discovery of a Potent, selective and orally bioavailable CDK9 degrader for targeting transcription regulation in Triple-Negative breast cancer
    Nie, Hui-Jun
    Li, Ben-Fu
    Sun, Jingya
    Yuan, Yali
    Zhang, Zhi-Gao
    Hu, Hao
    Wang, Wen-Jing
    Chen, Ziqiang
    Wang, Simei
    Huang, Wensi
    Diao, Xingxing
    Yu, Jinghua
    Huang, Ruimin
    Chen, Xiao-Hua
    BIOORGANIC CHEMISTRY, 2024, 153
  • [48] Narciclasine, a novel topoisomerase I inhibitor, exhibited potent anti-cancer activity against cancer cells
    Wang, Meichen
    Liang, Leilei
    Wang, Rong
    Jia, Shutao
    Xu, Chang
    Wang, Yuting
    Luo, Min
    Lin, Qiqi
    Yang, Min
    Zhou, Hongyu
    Liu, Dandan
    Qing, Chen
    NATURAL PRODUCTS AND BIOPROSPECTING, 2023, 13 (01)
  • [49] Narciclasine, a novel topoisomerase I inhibitor, exhibited potent anti-cancer activity against cancer cells
    Meichen Wang
    Leilei Liang
    Rong Wang
    Shutao Jia
    Chang Xu
    Yuting Wang
    Min Luo
    Qiqi Lin
    Min Yang
    Hongyu Zhou
    Dandan Liu
    Chen Qing
    Natural Products and Bioprospecting, 2023, 13
  • [50] Sy-1365, a Potent and Selective CDK7 Inhibitor, Exhibits Anti-Tumor Activity in Preclinical Models of Hematologic Malignancies, and Demonstrates Interactions with the BCL-XL/BCL2 Mitochondrial Apoptosis Signaling Pathway in Leukemia
    Hodgson, Graeme
    Johannessen, Liv
    Rajagopal, Nisha
    Hu, Shanhu
    Orlando, David
    Eaton, Matthew
    McKeown, Michael
    Tyner, Jeffrey W.
    Kurtz, Stephen E.
    Sprott, Kevin
    Fritz, Christian
    Di Tomaso, Emmanuelle
    BLOOD, 2017, 130
12345